4
Changes in Ownership
PTC THERAPEUTICS, INC. Filed Acc 0001415889-25-001291
EXEC. VP AND CLO sold 3,541 shares at an average $44.87 ($158,871)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Boulding Mark Elliott · EXEC. VP AND CLO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-07 | Sale : show line 1 in the form 10b5-1 | −1,543 | $45.34 | $69,960 | 108,846 | D |
| 2025-01-08 | Sale : show line 2 in the form 10b5-1 | −1,998 | $44.50 | $88,911 | 106,848 | D |
| Open-market sales · 3,541 sh · avg $44.87 · $158,871 | ||||||
Loading xslF345X05/form4-01102025_050103.xml…